FATE Message Board Post 9840524 | Fate Therapeutics Inc.
home / stock / fate / fate message board
nipsy516
(investorshub)
Posted on: Mar/15/2023 23:51:44
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171456368
Preclinical data on an anti-CXCR5 CAR https://www.nature.com/articles/s41467-020
News, Short Squeeze, Breakout and More Instantly...
-
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgr...
-
First Lupus Patient Treated with FT819 CAR T-cell Product Candidate in Phase 1 Autoimmunity Study; Future Clinical Development of FT819 to Focus Exclusively on Autoimmune Disease Enrollment Initiated with FT522 CAR NK Cell Product Candidate in Conditioning-free Treatment Arm of Phase 1 ...
-
Pre-treatment Sample of Patient’s Blood Showed Rapid and Potent Depletion of CD19+ B Cells in Ex Vivo Cytotoxicity Assay with FT819 Translational Data from FT819 Phase 1 B Cell Malignancies Study Support Key Therapeutic Mechanisms of Activity for B Cell-mediated Autoimmune Diseas...